Skip to main content
. 2017 May 10;8(26):43104–43113. doi: 10.18632/oncotarget.17763

Table 2. Gender and age ranges of the three groups of research subjects.

Patient group Negative control Normal control
n % n % n %
Gender Male 11 55.00 8 40.00 10 50.00
Female 9 45.00 12 60.00 10 50.00
Age (years) 20-40 4 20.00 5 25.00 4 20.00
40-60 7 35.00 8 40.00 8 40.00
>60 9 45.00 7 35.00 8 40.00